Nyxoah SA logo

NYXH - Nyxoah SA Share Price

€21.3 -0.0  -0.1%

Last Trade - 4:35pm

Sector
Healthcare
Size
Mid Cap
Market Cap £409.1m
Enterprise Value £396.2m
Revenue £n/a
Position in Universe 334th / 846
Bullish
Bearish
Unlock NYXH Revenue
Momentum
Relative Strength (%)
1m +12.7%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -14.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Nyxoah SArevenues was not reported. Net loss increased 11% to EUR4M.Higher net loss reflects General & Administrative Expensesincrease of 86% to EUR2.1M (expense), Therapy DevelopmentExpense increase from EUR319K to EUR761K (expense),Financial Expense increase of 8% to EUR416K (expense).Basic Earnings per Share excluding Extraordinary Itemsremained flat at -EUR0.24.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

NYXH Revenue Unlock NYXH Revenue

Net Income

NYXH Net Income Unlock NYXH Revenue

Normalised EPS

NYXH Normalised EPS Unlock NYXH Revenue

PE Ratio Range

NYXH PE Ratio Range Unlock NYXH Revenue

Dividend Yield Range

NYXH Dividend Yield Range Unlock NYXH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
NYXH EPS Forecasts Unlock NYXH Revenue
Profile Summary

Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated July 15, 2009
No. of Shareholders: n/a
No. of Employees: 54
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Euronext - Brussels
Shares in Issue 22,074,109
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NYXH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NYXH
Upcoming Events for NYXH
Frequently Asked Questions for Nyxoah SA
What is the Nyxoah SA share price?

As of 4:35pm, shares in Nyxoah SA are trading at €21.3, giving the company a market capitalisation of £409.1m. This share price information is delayed by 15 minutes.

How has the Nyxoah SA share price performed this year?

Shares in Nyxoah SA are currently trading at €21.3 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Nyxoah SA price has moved by % over the past year.

What are the analyst and broker recommendations for Nyxoah SA?

There are no analysts currently covering Nyxoah SA.

When will Nyxoah SA next release its financial results?

Nyxoah SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Nyxoah SA dividend yield?

Nyxoah SA does not currently pay a dividend.

Does Nyxoah SA pay a dividend?

Nyxoah SA does not currently pay a dividend.

When does Nyxoah SA next pay dividends?

Nyxoah SA does not currently pay a dividend.

How do I buy Nyxoah SA shares?

To buy shares in Nyxoah SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Nyxoah SA?

Shares in Nyxoah SA are currently trading at €21.3, giving the company a market capitalisation of £409.1m.

Where are Nyxoah SA shares listed? Where are Nyxoah SA shares listed?

Here are the trading details for Nyxoah SA:

Country of listing: Belgium
Exchange: BRU
Ticker Symbol: NYXH
What kind of share is Nyxoah SA?

Based on an overall assessment of its quality, value and momentum, Nyxoah SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Nyxoah SA share price forecast 2021?

We were not able to load any forecast data for Nyxoah SA.

How can I tell whether the Nyxoah SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nyxoah SA. Over the past six months, the relative strength of its shares against the market has been %. At the current price of €21.3, shares in Nyxoah SA are trading at 21.13% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Nyxoah SA PE Ratio?

We were not able to find PE ratio data for Nyxoah SA.

Who are the key directors of Nyxoah SA?

We were unable to find the directors for Nyxoah SA.

Who are the major shareholders of Nyxoah SA?

Here are the top five shareholders of Nyxoah SA based on the size of their shareholding:

Cochlear Limited Corporation
Percentage owned: 18.01% (3.98m shares)
Gilde Healthcare Partners B.V. Venture Capital
Percentage owned: 14.9% (3.29m shares)
Taub (Robert MBA) Individual Investor
Percentage owned: 12.84% (2.83m shares)
Monden (Anneliese) Individual Investor
Percentage owned: 11.51% (2.54m shares)
Hambrecht (Jürgen) Individual Investor
Percentage owned: 4.78% (1.05m shares)
Similar to NYXH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.